EastWest Bioscience Issues a Correction to the News Release Distributed on May 28, 2020

Author's Avatar
Aug 20, 2021

PENTICTON, BC / ACCESSWIRE / August 20, 2021 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST, Financial) reports that, on July 8, 2020, the US Securities and Exchange Commission (the "SEC") issued an order of suspension of trading in shares of EastWest traded on the US "over-the-counter" market (the "Order"). The Order referenced the accuracy and adequacy of information that was contained in the press release of EastWest distributed on May 28, 2020 regarding the U.S. Food and Drug Administration's (the "FDAs") approval of the Company's hand sanitizers (entitled "Eastwest Bioscience 80% Ethyl Alcohol Hand Sanitizer Receives FDA Approval").